Shoichi Hazama

9PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 12, 2020
Serum LOX-1 is a novel prognostic biomarker of colorectal cancer.

Chiyo Nakashima-Nakasuga, Shoichi Hazama, Nobuaki Suzuki

|Jul 12, 2019
Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genes.

Takafumi Oga, Yoshihiro Yamashita, Manabu Soda

|Jul 14, 2018
Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy.

Shoichi Hazama, Koji Tamada, Yoshiyuki Yamaguchi

Pageof 2